Abstract
Introduction: HIV testing remains central to epidemic control, yet status awareness in Zimbabwe remains below UNAIDS targets. We evaluated a targeted testing model integrating risk screening with optimized index testing.Methods: We conducted a convergent mixed-methods study across eight provinces, April 2021-June 2022. A five-question HIV risk screening tool was evaluated, screen‑negative clients were offered HIV self-testing or scheduled testing. Performance metrics included sensitivity, specificity, positive predictive value, and number needed to test (NNT). Twenty in-depth interviews with healthcare providers were conducted in sampled primary, secondary and tertiary facilities to explore implementation enablers and barriers. Index testing was assessed through cascade analysis of 6,308 index cases across 50 facilities, using logistic regression to identify predictors of positivity. Programme fidelity was evaluated using a logical framework.Results: The screening tool achieved 94.1% sensitivity, 65.8% specificity, and reduced testing volume by 18.0% (NNT=11). In the Index testing cascade, 66.4% of index cases were offered testing; of 5,080 elicited contacts, 78.6% were tested, yielding 56.5% positivity and 91.8% linkage. Predictors of positivity included anonymous tracing (aOR 8.46; 95% CI 3.37–22.75), testing within seven days (aOR 2.78; 95% CI 2.44–3.18), male sex (aOR 3.09; 95% CI 2.74–3.49), and first‑time testers (aOR 1.65; 95% CI 1.43–1.91). Programme fidelity ranged from 62.2% to 81.8%, with barriers in SOP use, staffing, and tools.Conclusion: This comprehensive evaluation of Zimbabwe’s targeted HIV testing strategy demonstrated that combining a validated screening tool with optimized Index testing improves efficiency, yield, and linkage. The output (revised model) informed national guidelines review.